The company's low P/E is due to its outlook for shrinking earnings. Investors believe the potential for earnings improvement doesn't justify a higher P/E, limiting the chances of a strong share price rise soon.
Quanex Building Products is undervalued, presenting a good opportunity to increase holdings. The company's future outlook isn't fully reflected in the current share price, making it a good time to invest.
The large scale share sell-off from the Independent Lead Director around current prices raises concern. Lack of recent insider purchases despite significant ownership increases caution towards the company.
Gainers: •$Okta (OKTA.US)$+15.8% (In reaction to earnings) •$StoneCo (STNE.US)$+12.9% (In reaction to earnings) •$Turning Point Therapeutics (TPTX.US)$+116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025) •$Amylyx Pharmaceuticals (AMLX.US)$+24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
lightfoot
:
This will be a solid stock and add it to your portfolio. I see NX a growth stock. financials are sound. Sales now. Beware of Biden recession A time to buy like the Mortgage bubble in 2008-9.
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Quanex Building Products Stock Forum
In reaction to earnings/guidance:
• $HashiCorp (HCP.US)$ +16.8%, $Lululemon Athletica (LULU.US)$ +9.7%, $PagerDuty (PD.US)$ +5%, $nCino (NCNO.US)$ +3.8% (also Bank Operating System selected by Rabobank Australia and New Zealand), $Broadcom (AVGO.US)$ +2.1%
Other news:
• $Ooma (OOMA.US)$ +3.5% (acquires Junction Networks also reports earnings)
• $Momentus (MNTS.US)$ +3.5% (files for $200 mln mixed securities shelf offering)
• $Humacyte (HUMA.US)$ +2.9% (fi...
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet